Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study (Q74507662)
scientific article published on 01 April 1998
Language:
(P31) (Q13442814)
(P304) 641-648
(P407) (Q1860)
(P433) 4
(P478) 21
(P577) Wednesday, April 1, 1998
Wednesday, April 1, 1998
(P921) (Q3025883)
(Q269829)
(Q106807541)
(Q389735)
(Q1717246)
(P953) https://diabetesjournals.org/care/article-pdf/21/4/641/664270/21-4-641.pdf
(P1433) (Q5270111)
(P1476) "Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study" (language: en)
"Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study" (language: en)
(P2093) R. S. Elkeles
J. R. Diamond
C. Poulter
S. Dhanjil
A. N. Nicolaides
S. Mahmood
W. Richmond
H. Mather
P. Sharp
M. D. Feher
other details
description scientific article published on 01 April 1998

External Links